Neurofilaments as biomarkers in neurological disorders

M Khalil, CE Teunissen, M Otto, F Piehl… - Nature Reviews …, 2018 - nature.com
Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage …

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis

C Bridel, WN Van Wieringen, H Zetterberg… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …

Neurofilaments: neurobiological foundations for biomarker applications

AR Gafson, NR Barthélemy, P Bomont, RO Carare… - Brain, 2020 - academic.oup.com
Interest in neurofilaments has risen sharply in recent years with recognition of their potential
as biomarkers of brain injury or neurodegeneration in CSF and blood. This is in the context …

A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples

N Wongpakaran, T Wongpakaran, D Wedding… - BMC medical research …, 2013 - Springer
Background Rater agreement is important in clinical research, and Cohen's Kappa is a
widely used method for assessing inter-rater reliability; however, there are well documented …

Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia

F Verde, M Otto, V Silani - Frontiers in neuroscience, 2021 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two related
currently incurable neurodegenerative diseases. ALS is characterized by degeneration of …

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

LH Meeter, EG Dopper, LC Jiskoot… - Annals of clinical …, 2016 - Wiley Online Library
Objective To evaluate cerebrospinal fluid (CSF) and serum neurofilament light chain (NfL)
levels in genetic frontotemporal dementia (FTD) as a potential biomarker in the …

Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease

A Gaiani, I Martinelli, L Bello, G Querin… - JAMA …, 2017 - jamanetwork.com
Importance A clearer definition of the role of neurofilament light chain (NFL) as a biomarker
in amyotrophic lateral sclerosis (ALS) is needed. Objectives To assess the ability of NFL to …

Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects

FH Kobeissy - 2015 - books.google.com
With the contribution from more than one hundred CNS neurotrauma experts, this book
provides a comprehensive and up-to-date account on the latest developments in the area of …

Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers

E Zucchi, V Bonetto, G Sorarù, I Martinelli… - Molecular …, 2020 - Springer
Motor neuron diseases (MNDs) are etiologically and biologically heterogeneous diseases.
The pathobiology of motor neuron degeneration is still largely unknown, and no effective …

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

M Stangel, S Fredrikson, E Meinl, A Petzold… - Nature Reviews …, 2013 - nature.com
Diagnosis of multiple sclerosis (MS) requires the exclusion of other possible diagnoses. For
this reason, the cerebrospinal fluid (CSF) should be routinely analysed in patients with a first …